The goal of this clinical trial is to assess the effect of melatonin on MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis. The main question aim to answer : • Does melatonin affect MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis? The participants in the treatment group will receive a single dose of oral melatonin 20 mg, meanwhile those the control group will receive placebo. The researchers will compare MDA serum, IL-6, IL-8 levels, ANC, and sepsis score before and after receiving melatonin, whether there are decreases of MDA serum, IL-6, IL-8 levels, ANC and increase of sepsis score
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
42
The control group will receive standard therapy and placebo.
The participants in the treatment group will receive standard therapy and a single dose of oral melatonin 20 mg
Dwi Hidayah
Surakarta, Central Java, Indonesia
Number of Participants with Treatment-Related Improvement of Sepsis Score Based on Gitto Scoring System
Time frame: From enrollment to the end of treatment at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.